⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1670621 | 1.00 | — | — | |
| SCHEMBL420637 | 1.00 | — | — | |
| SCHEMBL85607 | 1.00 | — | — | |
| SCHEMBL2562267 | 1.00 | — | — | |
| SCHEMBL56195 | 1.00 | — | — | |
| SCHEMBL578646 | 1.00 | — | — | |
| SCHEMBL5346790 | 1.00 | — | — | |
| SCHEMBL7738881 | 1.00 | — | — | |
| SCHEMBL30484837 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3413778 | 0.97 | PEPD (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110582493-A | Benzoxazole derivatives as immunomodulators | 因赛特公司 | 2019-12-17 | — | — | CN | claimed |
| WO-2018047148-A1 | COMPOUNDS FOR THE INHIBITION OF MIRNA | NOVARTIS AG (CH) | 2018-03-15 | — | — | WO | claimed |
| EP-3966226-B1 | MASP INHIBITORY COMPOUNDS AND USES THEREOF | BAYER AG (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-12503491-B2 | MASP inhibitory compounds and uses thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2025-12-23 | — | — | US | disclosed |
| EP-3746064-B1 | COMPOUNDS FOR USE IN THE TREATMENT OF ACUTE BRAIN INJURY | UNIV COPENHAGEN (DK) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025022003-A1 | BETA-PEPTIDES WITH CYTOTOXIC ACTIVITY ON CANCER CELLS | Universität Linz (AT) | 2025-01-30 | — | — | WO | disclosed |
| US-20240391865-A1 | COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY | OTAGO INNOVATION LIMITED (NZ) | 2024-11-28 | — | — | US | disclosed |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| US-12077495-B2 | Compounds for the treatment of acute brain injury | Københavns Universitet (DK) | 2024-09-03 | — | — | US | disclosed |
| US-20240124522-A1 | MASP INHIBITORY COMPOUNDS AND USES THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-18 | — | — | US | disclosed |
| US-20230303647-A1 | CYCLIC CHEMERIN-9 DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-09-28 | — | — | US | disclosed |
| US-6958384-B2 | Polypeptides containing γ-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-10-25 | — | — | US | disclosed |
| US-20040116654-A1 | Heterogeneous foldamers containing alpha, beta, and/or gamma-amino acids | NATIONAL SCIENCE FOUNDATION | 2004-06-17 | — | — | US | disclosed |
| WO-2004018644-A2 | HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-04 | — | — | WO | disclosed |
| US-6683154-B1 | UNNATURAL CATIONIC OLIGOMERS THAT HAVE NO KNOWN NATURAL COUNTERPART AND THAT DISPLAY ANTIBIOTIC ACTIVITY COMPARABLE TO THAT OF MAGAININ DERIVATIVE AGAINST AT LEAST FOUR DIFFERENT BACTERIAL SPECIES, YET EXHIBIT LOWER HEMOLYTIC ACTIVITY | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-01-27 | — | — | US | disclosed |
| US-20030211999-A1 | Polypeptides containing gamma-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-11-13 | — | — | US | disclosed |
| US-6613876-B1 | Covalently linking subunit of given formula to a plurality of separable solid substrates; deprotecting; used for generating combinatorial libraries | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-09-02 | — | — | US | disclosed |
| WO-2003008439-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING β-AMINO ACID OLIGOMERS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2003-01-30 | — | — | WO | disclosed |
| US-20020037997-A1 | Beta-amino acids | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-03-28 | — | — | US | disclosed |
| US-6060585-A | β-polypeptide foldamers of well-defined secondary structure | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2000-05-09 | — | — | US | disclosed |